Role of Thrombophilia in Vascular Access Thrombosis Among Chronic Hemodialysis Patients in Tunisia

Therapeutic Apheresis and Dialysis

Volumn 15, Issue 1, 2011, Pages 40-43

  Fekih Mrissa, Najiba ^a   Klai, Sarra ^a   Bafoun, Anis ^b   Nciri, Brahim ^a   Hmida, Jalel ^b   Gritli, Nasredine ^a  

^a Laboratory of Molecular Biology   (Tunisia)

^b MILITARY HOSPITAL OF TUNIS   (Tunisia)

Author keywords

Hemodialysis; Hypercoagulability; Thrombophilia; Vascular access thrombosis

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); ANTITHROMBIN; BLOOD CLOTTING FACTOR 5 LEIDEN; PROTEIN C; PROTEIN S; PROTHROMBIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE MUTATION; HEMODIALYSIS PATIENT; HUMAN; HYPERCOAGULABILITY; MALE; PRIORITY JOURNAL; THROMBOPHILIA; THROMBOSIS; TUNISIA; VASCULAR ACCESS;

ADULT; AGED; ARTERIOVENOUS SHUNT, SURGICAL; CASE-CONTROL STUDIES; CHRONIC DISEASE; GRAFT OCCLUSION, VASCULAR; HUMANS; KIDNEY FAILURE, CHRONIC; MIDDLE AGED; RENAL DIALYSIS; THROMBOPHILIA; THROMBOSIS; TUNISIA;

EID: 79251558131     PISSN: 17449979     EISSN: 17449987     Source Type: Journal    
DOI: 10.1111/j.1744-9987.2010.00848.x     Document Type: Article

References (16)

1. Lazo-Langer A, Knoll GA, Wells PS, Carson N, Rodger MA. The risk of dialysis access thrombosis is related to the transforming growth factor-beta1 production haplotype and is modified by polymorphisms in the plasminogen activator inhibitor-type 1 gene. Blood 2006;108:4052-8.
2. Hojs R, Gorenjak M, Ekart R, Dvoršak B, Pečovnik-Balon B. Homocysteine and vascular access thrombosis in hemodialysis patients. Ren Fail 2002;24:215-22.
3. Feng-Rong C, Te-Chuan C, Chih-Chao Y etal. Igm-anticardiolipin antibody and Vascular access thrombosis in chronic hemodialysis patients. Ren Fail 2005;27:25-30.
4. Klamroth R, Seibt F, Rimpler H, Landgraf H. Recurrent vascular access site thrombosis in patients on hemodialysis-a problem of thrombophilia? Blood 2004;104:1053. Abstract 4018.
5. Zotz R, Steuer S, Zimmermann M etal. Platelet receptor polymorphism HPA-1b and the G20210A mutation of the prothrombin-gene are risk determinants of vascular access thrombosis in hemodialysis patients. J Thromb Haemost 2003;1(Suppl 1):Abstract number: P1486.
6. Knoll GA, Wells PS, Young D etal. Thrombophilia and the risk for hemodialysis vascular access thrombosis. J Am Soc Nephrol 2005;16:1108-14.
7. Sands JJ, Nudo SA, Moore KD, Ortel TL. Antibodies to prothrombin, factor V, and 2-glycoprotein I and vascular access thrombosis. ASAIO J 2001;47:507-10.
8. Fukasawa M, Matsushita K, Kamiyama M etal. The methylentetrahydrofolate reductase C677T point mutation is a risk factor for vascular access thrombosis in hemodialysis patients. Am J Kidney Dis 2003;41:637-42.
9. Bowden RG, Wyatt FB, Wilson R, Wilborn C, Gentile M. Homocysteine, age, gender and vascular access thrombosis in end-stage renal disease patients: retrospective analysis. J Argent Fed Cardiol Internet Published under Brief Communications in: Cerebral and Peripheral Vascular Disease 2003.
10. Carrier M, Knoll GA, Kovacs MJ, Moore JC, Fergusson D, Rodger MA. The prevalence of antibodies to the platelet factor 4 -heparin complex and association with access thrombosis in patients on chronic hemodialysis. Thromb Res 2007;120:215-20.
11. Crowther MA, Kelton JG. Congenital thrombophilic states associated with venous thrombosis: a qualitative overview and proposed classification system. Ann Intern Med 2003;138:128-34.
12. O'Shea SI, Lawson JH, Reddan D, Murphy M, Ortel TL. Hypercoagulable states and antithrombotic strategies in recurrent vascular access site thrombosis. J Vas Surg 2003;38:541-8.
13. Akman B, Afsar B, Ataç FB etal. Predictors of vascular access thrombosis among patients on the cadaveric renal transplantation waiting list. Transplant Proc 2006;38:413-15.
14. Girndt M, Heine GH, Ulrich C, Köhler H. Gene polymorphism association studies in dialysis: vascular access. Semin Dial 2007;20:63-7.
15. Chih-Ching L, Wu-Chang Y. Prognostic factors influencing the patency of hemodialysis vascular access: literature review and novel therapeutic modality by far infrared therapy. J Chin Med Assoc 2009;72:109-16.
16. Rios DRA, Guimarães DA, Gomes KB etal. Role of genetic mutations in vascular access thrombosis among hemodialysis patients. J Thromb Haemost 2009;7(Suppl 2): Abstract PP-WE-310.